Quantum Biopharma (QNTM) Equity Average (2024 - 2026)
Quantum Biopharma recorded quarterly Equity Average of $3.8 million in Q1 2026, down 51.72% quarter-over-quarter from $7.8 million in Q4 2025, and down 56.31% year-over-year from $8.6 million in Q1 2025.
Quantum Biopharma's Equity Average history runs 3 years deep, the most recent figure standing at $3.8 million for Q1 2026.
- In Q1 2026, Equity Average fell 56.31% year-over-year to $3.8 million; the TTM figure through Mar 2026 stood at $3.8 million (down 56.31% YoY), while the FY2025 annual figure was $9.2 million, changed N/A from the prior year.
- Equity Average came in at $3.8 million for Q1 2026 at Quantum Biopharma, down from $7.8 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $13.9 million in Q4 2024 to a low of $3.8 million in Q1 2026.
- A 3-year average of $8.4 million and a median of $7.8 million in 2025 frame the typical range for Equity Average.
- Across the five-year window, Equity Average slumped 43.91% in 2025 and tumbled 56.31% in 2026, its largest moves.
- Quantum Biopharma's Equity Average stood at $13.9 million in 2024, then plunged by 43.91% to $7.8 million in 2025, then plunged by 51.72% to $3.8 million in 2026.
- According to Business Quant data, Equity Average over the past three periods registered $3.8 million, $7.8 million, and $6.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 3.76 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 21.35 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.01 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.34 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 932.28 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 1.57 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.76 Mn |
| Dec 31, 2025 | 7.79 Mn |
| Sep 30, 2025 | 6.21 Mn |
| Jun 30, 2025 | 4.75 Mn |
| Mar 31, 2025 | 8.61 Mn |
| Dec 31, 2024 | 13.89 Mn |
| Sep 30, 2024 | 13.62 Mn |